Bone mineral density (BMD) of patients with beta thalassemia Thalassemia Research Center 2007 - Journal of Mazandaran University of Medical Sciences
Volume 21, Number 86 (Feb 2012)                   J Mazandaran Univ Med Sci 2012, 21(86): 63-73 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kosaryan M, Vahidshahi K, Emadi jamali A, Sarparast L. Bone mineral density (BMD) of patients with beta thalassemia, Thalassemia Research Center, 2007. J Mazandaran Univ Med Sci. 2012; 21 (86) :63-73
URL: http://jmums.mazums.ac.ir/article-1-857-en.html

Abstract:   (9878 Views)
Background and purpose: Osteopenia and osteoporosis are well known and common complications of beta thalassemia major (TM). This research was undertaken in order to find the prevalence and related factors and also effect of ongoing treatment on the conditions. Materials and methods: All medical records of patients older than 16 years were reviewed. Non transfusion dependent patients called as thalassemia intermediate. Demography of patients was extracted, the results of the BMD and Z-Score of femoral neck and lumbar vertebrae were reported comparing normal matched subjects. Z-Scores <-1, -1 to -2.5, and bigger than -2.5 were considered as normal, osteopenic and osteoporotic respectively. Results: 125 patients had at least one BMD measurement. 73(58%) patients were TM and the remainders were non transfusion dependent. Mean age was 24 ± 6 and F/M ratio was 3/1. According to Z-Scores, 17% , 61% and 17% were normal, osteopenic and osteoporotic respectively. Age and severity of pathology were correlated, and 7% reduction of BMD/ year was calculated (P<0.000). BMD of lumbar vertebra was worse in men (P<0.001). A negative significant correlation was detected between BMD and the mean of hematocrit in the last 5 years (P<0.005). Correlation of the age at starting transfusion and severity of BMD was not significant. Nineteen patients had 2 BMD measurements, 3 ± 1 years apart. Patients who had osteoporosis in the first measurements were using oral medicine (Alendronate). No significant improvement was noticed and in fact femoral BMD was worse in men (P<0.001). Conclusion: BMD measurements was less than anticipated. Osteopenia and even osteoporosis are common. Treatment duo to non compliance or inadequacy was not effective and more intensive treatment is needed.
Full-Text [PDF 308 kb]   (1501 Downloads)    
Type of Study: Research(Original) |

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb